WHO ICTRP trial
Hypofractionated Radiotherapy in Locally Advanced Carcinomas of the Cervix
CTRI/2018/04/013243 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2018/04/013243 |
|---|---|
| Public title | Hypofractionated Radiotherapy in Locally Advanced Carcinomas of the Cervix |
| Scientific title | Local Control and Toxicity Profile in Patients of Locally Advanced Carcinomas of the Cervix (Stage IIIb Disease) Treated with Hypofractionated Radiotherapy |
| Primary sponsor | Jawaharlal Institute of Postgraduate Medical Education and Research |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1/ Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: null- Patients of hitologically proven cervical cancer |
| Interventions | Intervention1: Hypofractionated External Beam Radiotherapy: External beam radiotherapy at 2.25 gray per fraction with a total dose of 45Gy in 20 fractions with additional 4.5Gy in 2 fractions with midline shield over 4 to 4.5 weeks Control… |
| Registration date | Apr 13, 2018 |
| Target size | 96 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: